MedAvail Technologies Adds David Rawlins as Chief Strategy Officer

Ad blocking detected

Thank you for visiting CanadianInsider.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). Private browsing Firefox users should be able to disable tracking protection while visiting our website. Visit Mozilla support for more information. If you do not believe you have any ad-blocking software on your browser, you may want to try another browser, computer or internet service provider. Alternatively, you may consider the following if you want an ad-free experience.

Canadian Insider Ultra Club
$500/ year*
Daily Morning INK newsletter
+3 months archive
Canadian Market INK weekly newsletter
+3 months archive
30 publication downloads per month from the PDF store
Top 20 Gold, Top 30 Energy, Top 40 Stock downloads from the PDF store
All benefits of basic registration
No 3rd party display ads
JOIN THE CLUB

* Price is subject to applicable taxes.

Paid subscriptions and memberships are auto-renewing unless cancelled (easily done via the Account Settings Membership Status page after logging in). Once cancelled, a subscription or membership will terminate at the end of the current term.

MedAvail Technologies Adds David Rawlins as Chief Strategy Officer

David Rawlins to Develop and Maintain In-Market Partnerships, Including Medicare Business for MedAvail.

PR Newswire

TORONTO, May 28, 2019 /PRNewswire-PRWeb/ -- Healthcare technology company MedAvail has hired David Rawlins as its new chief strategy officer. Rawlins will be responsible for MedAvail's overall business strategy with an initial focus on further developing an already growing Medicare business. He will also be involved in the day-to-day execution of a number of MedAvail's larger in-market partnerships.

Rawlins comes with an extensive background in strategic and financial analysis, most recently as managing director and then operating partner for Redmile Group since 2009. During his time at Redmile, Rawlins built its healthcare services business and worked closely with private portfolio companies on strategic and financial planning.

He brings with him an extensive knowledge and understanding of the complexities, regulations and incentives of the US healthcare system. Prior to his time at Redmile Group, Rawlins was vice president and then executive director for Morgan Stanley Equities between 2002 and 2009. He has a first-class master's degree in neuroscience and experimental psychology from Oxford University.

"We are excited to have David join our team," said Ed Kilroy, CEO of MedAvail Technologies. "David has sat on MedAvail's board of directors since April 2018. He will be an invaluable asset to our company as we continue to strategically collaborate and leverage our state-of-the-art technology to provide the most advanced self-serve pharmacy solutions anywhere, any time to millions of Americans."

For more information about MedAvail, visit MedAvail.com.

MedAvail Technologies Inc.
MedAvail is a healthcare technology company that has developed and commercialized an innovative self-serve pharmacy kiosk solution. The MedAvail MedCenter® supports the dispensing of prescription drugs and over-the-counter medications. MedAvail has deployed kiosks in the US, Canada and Switzerland in use cases that include employer sites, retail pharmacies, retail stores without traditional pharmacies, hospital emergency rooms, urgent cares, community clinics, universities and medical office buildings.

 

SOURCE MedAvail Technologies

Copyright CNW Group 2019

Comment On!

140
Upload limit is up to 1mb only
To post messages to your Socail Media account, you must first give authorization from the websites. Select the platform you wish to connect your account to CanadianInsider.com (via Easy Blurb).